Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.

World journal of gastroenterology - 14 Jan 2015

Hou Ke-Zhu, Fu Zhi-Qiang, Gong Hua

Abstract excerpt

AIM: To identify the mechanisms of chemokine ligand 20 (CCL20)-induced hepatocellular carcinoma (HCC) metastasis and evaluate it as a prognostic marker. METHODS: Expression of CCL20 was evaluated by immunohistochemistry in HCC tissues from 62 patients who underwent curative resection. The relationship between CCL20 expression and clinicopathologic features was analyzed. Univariate and multivariate analyses were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial-Mesenchymal Transition

Share to Kaplan-Meier Estimate

Share to Liver Neoplasms

Share to Multivariate Analysis

Share to Neoplasm Recurrence, Local

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 25593462
DOI: 10.3748/wjg.v21.i2.475
PMCID: PMC4292278

Genes

CCL20

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.PMID 25593462Read ↗

CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary cultureSemantic proximity Read ↗

CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosisSemantic proximity Read ↗

Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.Semantic proximity Read ↗

CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.Semantic proximity Read ↗

Crucial biological functions of CCL7 in cancerSemantic proximity Read ↗

[Influence of CCL21 on the invasion and metastasis of colorectal cancer].Semantic proximity Read ↗

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targetingSemantic proximity Read ↗

CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell LinesSemantic proximity Read ↗

Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.Semantic proximity Read ↗

Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinomaSemantic proximity Read ↗

Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin PathwaySemantic proximity Read ↗

Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.